Back to search

Article

Single-AAV CRISPR editing of skeletal muscle in non-human primates with NanoCas, an ultracompact nuclease

2025-01-30

Abstract excerpt

CRISPR gene editing is a transformative technology for addressing genetic diseases, but delivery constraints have largely limited its therapeutic applications to liver-targeted and ex vivo therapies. Here, we present the discovery and engineering of NanoCas, an ultracompact CRISPR nuclease capable of extending CRISPR’s reach in vivo beyond liver targets. We experimentally screened 176 ultracompact CRISPR systems...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37a7a07b-3498-5186-93cc-a4dd09b2bca5
DOI
10.1101/2025.01.29.635576
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-AAV CRISPR editing of skeletal muscle in non-human primates with NanoCas, an ultracompact nucleaseDOI 10.1101/2025.01.29.635576
Select a neighboring publication to make it the new centre.